Brendon Binneman

A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH ₁ Antagonist) in the Treatment of Major Depression

Brendon Binneman, Douglas E. Feltner, Sheela Kolluri et al. · American Journal of Psychiatry · 2008 · 250 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Longitudinal study of symptoms and cognitive function in chronic schizophrenia

Catherine Hughes, Veena Kumari, W. Soni et al. · Schizophrenia Research · 2002 · 215 citations

Medicine, Psychiatry, Psychology +16

Ponezumab in mild‐to‐moderate Alzheimer's disease: Randomized phase II PET‐PIB study

Jaren W. Landen, Niels Andreasen, Carol Cronenberger et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2017 · 65 citations · Full text

Medicine, Neurology, Pharmacology +17

Multiple‐dose ponezumab for mild‐to‐moderate Alzheimer's disease: Safety and efficacy

Jaren W. Landen, Sharon Cohen, Clare B. Billing et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2017 · 62 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil

Terence Fullerton, Brendon Binneman, William David et al. · Alzheimer s Research & Therapy · 2018 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17